01 6LA JOLLA PHARMA
01 69220745
01 6Blank
01 6Blank
01 62034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 9220745
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2217
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 9220745
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2217
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 9220745
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2218
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 9220745
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2218
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 9220745
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2217
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
Patent Expiration Date : 2034-12-18
US Patent Number : 9220745
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2218
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-12-18
